Ohara, Ako Matsushita
Naoi, Yasuto http://orcid.org/0000-0002-6090-0137
Shimazu, Kenzo
Kagara, Naofumi
Shimoda, Masafumi
Tanei, Tomonori
Miyake, Tomohiro
Kim, Seung Jin
Noguchi, Shinzaburo
Article History
Received: 26 August 2018
Accepted: 17 October 2018
First Online: 25 October 2018
Compliance with ethical standards
:
: Dr. Shinzaburo Noguchi has been an advisor for Taiho, AstraZeneca and Novartis, and has received research funding for other studies from Sysmex, AstraZeneca, Novartis, Chugai, Daiichi-Sankyo, Kyowa-Kirin, Takeda, Pfizer, Ono, Taiho, and Eisai, and honoraria from AstraZeneca, Novartis, Pfizer, Chugai, Takeda, Sysmex, Nippon Kayaku, and Ono. Dr. Yasuto Naoi has received research funding from Sysmex and AstraZeneca. Dr. Naofumi Kagara has received honoraria from AstraZeneca and Novartis. Dr. Masafumi Shimoda has received research funding from Novartis and AstraZeneca, and honoraria from Chugai, Eisai, Novartis, and Takeda. Dr. Kenzo Shimazu has received honoraria from AstraZeneca, Chugai, and Sysmex. Dr. Seung Jin Kim received honoraria from AstraZeneca, Chugai, Eisai, Kyowa-Kirin, Novartis, Pfizer, Shimadzu, Taiho, and Takeda.
: This study complies with the current relevant laws of and guidelines for Japan.